title: Reductions in insulin concentrations and β-cell mass precede growth restriction in sheep fetuses with placental insufficiency.
abstract: In pregnancy complicated by placental insufficiency (PI) and intrauterine growth restriction (IUGR), the fetus near term has reduced basal and glucose-stimulated insulin concentrations and reduced β-cell mass. To determine whether suppression of insulin concentrations and β-cell mass precedes reductions in fetal weight, which would implicate insulin deficiency as a cause of subsequent IUGR, we measured basal and glucose-stimulated insulin concentrations and pancreatic histology at 0.7 gestation in PI fetuses. Placental weights in the PI pregnancies were 40% lower than controls (265 ± 26 vs. 442 ± 41 g, P < 0.05), but fetal weights were not different. At basal conditions blood oxygen content, plasma glucose concentrations, and plasma insulin concentrations were lower in PI fetuses compared with controls (2.5 ± 0.3 vs. 3.5 ± 0.3 mmol/l oxygen, P < 0.05; 1.11 ± 0.09 vs. 1.44 ± 0.12 mmol/l glucose; 0.12 ± 0.01 vs. 0.27 ± 0.02 ng/ml insulin; P < 0.05). During a steady-state hyperglycemic clamp (~2.5 ± 0.1 mmol/l), glucose-stimulated insulin concentrations were lower in PI fetuses than controls (0.28 ± 0.02 vs. 0.55 ± 0.04 ng/ml; P < 0.01). Plasma norepinephrine concentrations were 3.3-fold higher (P < 0.05) in PI fetuses (635 ± 104 vs. 191 ± 91 pg/ml). Histological examination revealed less insulin area and lower β-cell mass and rates of mitosis. The pancreatic parenchyma was also less dense (P < 0.01) in PI fetuses, but no differences were found for pancreatic progenitor cells or other endocrine cell types. These findings show that hypoglycemia, hypoxemia, and hypercatecholaminemia are present and potentially contribute to lower insulin concentrations and β-cell mass due to slower proliferation rates in early third-trimester PI fetuses before discernible reductions in fetal weight.
authors.affiliation: Dept. of Animal Sciences, Univ. of Arizona, 1650 E. Limberlost Dr., Tucson, AZ 85719, USA. limesand@ag.arizona.edu
authors.forename: Sean W
authors.initials: SW
authors.lastname: Limesand
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Rozance
authors.forename: Antoni R
authors.initials: AR
authors.lastname: Macko
authors.forename: Miranda J
authors.initials: MJ
authors.lastname: Anderson
authors.forename: Amy C
authors.initials: AC
authors.lastname: Kelly
authors.forename: William W
authors.initials: WW
authors.lastname: Hay
mesh_terms: D000818:Animals; D001120:Arginine / Q000494:pharmacology; D001724:Birth Weight / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005317:Fetal Growth Retardation / Q000503:physiopathology*; D005333:Fetus / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D005947:Glucose / Q000494:pharmacology; D007150:Immunohistochemistry; D007328:Insulin / Q000097:blood*; D050417:Insulin-Secreting Cells / Q000502:physiology*; D018655:Lymphocyte Count; D008856:Microscopy, Fluorescence; D009638:Norepinephrine / Q000097:blood; D009929:Organ Size / Q000502:physiology; D010100:Oxygen / Q000097:blood; D010179:Pancreas / Q000473:pathology; D010927:Placental Insufficiency / Q000503:physiopathology*; D011247:Pregnancy; D012756:Sheep
chemical_list: D007328:Insulin; D001120:Arginine; D005947:Glucose; D010100:Oxygen; D009638:Norepinephrine